Belief BioMed Eyes Rare Disorders With AAV-Based Gene Therapies

New Hemophilia B Results At ASH

 
• By Xu Hu
  
Gene therapy R&D
Belief BioMed focuses on AAV-based gene therapies for rare disorders. (Shutterstock)

More from Gene Therapies

More from Conferences